middle.news
Why Did Four Opthea Directors Resign After Trial Failures?
11:47pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Why Did Four Opthea Directors Resign After Trial Failures?
11:47pm on Monday 2nd of June, 2025 AEST
Key Points
Four directors resign effective June 2, 2025
Phase 3 clinical trials fail to meet primary endpoints
65% workforce reduction announced in April 2025
Ongoing negotiations with Development Funding Agreement investors
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Opthea (ASX:OPT)
OPEN ARTICLE